Asia-Pacific Medical Cannabis Market Size, Share & Trends Analysis Report By Product Type (Solids, Dissolvable/Powders, Oil, Ointments and Creams), By Derivative (Cannabidiol, Tetrahydrocannabinol), By Route of Administrative (Inhalation, Oral, Topical), By Applications (Pain Management, Neurological Health Management, Mental Health Management), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Country (China, Korea, Japan, India, Australia, Taiwan, South East Asia, Rest of Asia-Pacific) Forecasts, 2025-2033

Report Code: SRHI54557DR

Last Updated: Jun, 2023

Pages: 110

Author: Debashree Bora

Format: PDF, Excel

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

ESG Trends

ESG Trends

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Flowers
  1. By Value
3. Concentrates
  1. By Value
4. Topicals & Transdermal Formulations
  1. By Value
5. Oils & Tinctures
  1. By Value
6. Other Product Types
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Chronic Pain Management
  1. By Value
4. Mental Health Management
  1. By Value
5. Neurological Disease Management
  1. By Value
6. Other Applications
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacies
  1. By Value
3. Drug Stores & Retail Pharmacies
  1. By Value
4. Online Pharmacies
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Flowers
    1. By Value
  3. Concentrates
    1. By Value
  4. Topicals & Transdermal Formulations
    1. By Value
  5. Oils & Tinctures
    1. By Value
  6. Other Product Types
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Chronic Pain Management
    1. By Value
  4. Mental Health Management
    1. By Value
  5. Neurological Disease Management
    1. By Value
  6. Other Applications
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacies
    1. By Value
  3. Drug Stores & Retail Pharmacies
    1. By Value
  4. Online Pharmacies
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Competitive Landscape

Asia-Pacific Medical Cannabis Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Canopy Growth Corporation
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Cannasr Sativa Inc.
Gw Pharmaceuticals Plc
Emerald Health Therapeutics
Tilray Inc.
Aurora Cannasr Inc.
Cara Therapeutics
Medical Marijuana Inc.
Gb Sciences Inc.
Canndoc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Table Of Content

Download Free Sample

We are featured on:

Table Of Content

Download Free Sample

We are featured on:

Debashree Bora

Healthcare Lead